Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy.

Abstract excerpt

Hydrophobic neoantigens are more immunogenic because they are better presented by the major histocompatibility complex and better recognized by T cells. Tumor cells can evade the immune response by expressing checkpoints such as programmed death ligand 1. Checkpoint blockade reactivates immune recognition and can be effective in diseases such as melanoma, which harbors a high tumor mutational burden (TMB)....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amino Acids
• Share to Antigens, Neoplasm